The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.
Authors:
- J M VinciJVJ M Vinci
- D HorwitzDHD Horwitz
- R M ZusmanRZR M Zusman
- J J PisanoJPJ J Pisano
- K J CattKCK J Catt
- H R KeiserHKH R Keiser
- 1 July 1979
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 1 (4) , 416-426
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The Kallikrein-Kinin System in Bartter's Syndrome and Its Response to Prostaglandin Synthetase InhibitionJournal of Clinical Investigation, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Activity of [Des-Aspartyl1]-Angiotensin II and Angiotensin II in ManJournal of Clinical Investigation, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Angiotensin-Converting Enzyme: Vascular Endothelial LocalizationScience, 1976
- Angiotensin I [Phe8-His9] hydrolase and bradykininase from human lungLife Sciences, 1975
- Fate of angiotensin I and II in the human pulmonary circulationThe American Journal of Cardiology, 1969
- Second Kininase in Human Blood PlasmaNature, 1967
- The Effect of Angiocardiographic Contrast Medium on Circulatory Dynamics in ManCirculation, 1965